Productivity of Young Experts in Hemostasis and Thrombosis before and during the SARS-CoV-2 Pandemic—A Special Issue

R.E. Scharf, Harvard Medical School, MD, PhD, FAHA

In September 2019, I invited Dr. Stefano Barco, Mainz/Zurich, who has recently been appointed a Junior Editorial Board Member, to design, organize and edit a special issue of Hämostaseologie—Progress in Haemostasis. Specifically, I asked Stefano to motivate a number of particularly successful members of the young scientific community from at home and abroad to submit contributions, which should reflect their current research activities in hemostasis and thrombosis. As an envisaged side effect of this initiative, I had in mind to bring international scientists among the authors closer to the Society of Thrombosis and Hemostasis Research (GTH) and to make them more familiar with GTH activities and its Journal. Vice versa, it was also intended to increase the awareness of young physician-scientists and young investigators conducting basic research with regard to their productivity and accomplishments among the GTH members.

• References

• 1 Van Es N, Ay C, Jara-Palomares L. Screening for occult cancer in patients with venous thromboembolism: past, present, and future. Hamostaseologie 2020; 40: 270-279
• 2 Gautam G, Sebastian T, Klok F. How to differentiate recurrent deep vein thrombosis from post-thrombotic syndrome. Hamostaseologie 2020; 40: 280-290
• 3 Giustozzi M, Castellucci L, Barnes G. Management of anticoagulant treatment and anticoagulation-related complications in nonagenarians. Hamostaseologie 2020; 40: 292-300
• 4 Valerio L, Riva N. Head, neck and abdominopelvic septic thrombophlebitis: current evidence and challenges in diagnosis and treatment. Hamostaseologie 2020; 40: 301-310
• 5 Trinchero A, Sholzberg M, Matino D. The evolution of hemophilia care: clinical and laboratory advances, opportunities and challenges. Hamostaseologie 2020; 40: 311-321
• 6 Roose E, Joly B. Current and future perspectives on ADAMTS13 and thrombotic thrombocytopenic purpura. Hamostaseologie 2020; 40: 322-336
• 7 Zaninetti C, Sachs L, Palankar R. Role of platelet cytoskeleton in platelet biomechanics: current and emerging methodologies and their potential relevance for the investigation of inherited platelet disorders. Hamostaseologie 2020; 40: 337-347
• 8 Bertoletti L, Mismetti V, Giannakoulas G. Use of anticoagulants in patients with pulmonary hypertension. Hamostaseologie 2020; 40: 348-355
• 9 Skeith L, Blondon M, Ní Áinle F. Understanding and preventing placenta-mediated pregnancy complications. Hamostaseologie 2020; 40: 356-363
• 10 Reda S, Morimont L, Douxfils J, Rühl H. Can we measure the individual prothrombotic or prohemorrhagic tendency by global coagulation tests?. Hamostaseologie 2020; 40: 364-378
• 11 Barco S. The millennial generation of thrombosis and hemostasis. Hamostaseologie 2020; 40: 259-261
• 12 Scharf RE. About mentees and mentors: what kind of advanced training should young scientists receive? - A personal reflection. Hamostaseologie 2020; 40: 379-381
• 13 Scharf RE. Haemostasis in times of COVID-19. Hamostaseologie 2020; 40: 141
• 14 Johns Hopkins Coronavirus Resource Center. Reported confirmed cases of COVID-19. Available at: www.coronavirus.jhu.edu 2020 . Accessed July 9, 2020
• 15 National Library of Medicine. Available at: www.nlm.nih.gov 2020 . Accessed July 9, 2020
• 16 Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 2020; DOI: 10.1111/jth.14849. [e-pub ahead of print]
• 17 Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res 2020; 190: 62
• 18 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; DOI: 10.1182/blood.2020006000. [e-pub ahead of print]
• 19 Gesellschaft für Thrombose- und Hämostaseforschung e. V. Aktualisierte Empfehlungen zur Thromboseprophylaxe bei SARS-CoV-2 (COVID-19). 2020 . Available at: www.gth-online.de . Accessed April, 2020
• 20 Langer F, Kluge S, Klamroth R, Oldenburg J. Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis. Hamostaseologie 2020; 40: 264-269